A synthetic peptide for use as a blocking control in assays to test for specificity of APOBEC3 F antibody, Alternative Names: ApoBEC3F control peptide, ApoBEC3F antibody Blocking Peptide, Anti-ApoBEC3F Blocking Peptide, Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide-Like 3F Blocking Peptide, ARP8 Blocking Peptide, BK150C2.4.MRNA Blocking Peptide, KA6 Blocking Peptide, MGC74891 Blocking Peptide
APOBEC3F
Reaktivität: Human
Wirt: Synthetic
BP, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
APOBEC3F
(Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3F (APOBEC3F))
Hintergrund
APOBEC3F is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been identified.